Document Detail


Intrauterine growth restriction.
MedLine Citation:
PMID:  16469319     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study reviewed the screening, diagnosis, prophylaxis, and treatment of intrauterine growth restriction using the PubMed database for key words and the Cochrane database for systematic reviews. Identification of risk factors and measurement of symphysis-fundus height are currently the screening standards. Diagnosis is verified by ultrasonography. Accuracy of diagnosis may be improved by using customized fetal growth curves, symphysis-fundus height charts, and 3-dimensional ultrasonographic evaluation and measuring umbilical artery Doppler dimensional ultrasonographic evaluation measuring umbilical artery Doppler impedance. Prophylaxis with acetylsalicylic acid, started in the first or second trimester or combined with heparin before conception, may reduce the incidence of growth restriction in specific groups at high risk. Active management may reduce incidence in patients with mild to moderate asthma, and targeted treatment of infections may also be beneficial. Antenatal corticosteroid treatment also reduces the perinatal morbidity and mortality associated with IUGR. Bed rest has no demonstrated beneficial effects.
Authors:
K Haram; E Søfteland; R Bukowski
Related Documents :
7675409 - Longitudinal monitoring of fetal behavior in twins when one is anencephalic.
2569329 - Activity of gamma-glutamyl transpeptidase in human fetal membranes.
8775669 - Preconception health care for the primary care practitioner.
Publication Detail:
Type:  Journal Article; Review     Date:  2006-02-08
Journal Detail:
Title:  International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics     Volume:  93     ISSN:  0020-7292     ISO Abbreviation:  Int J Gynaecol Obstet     Publication Date:  2006 Apr 
Date Detail:
Created Date:  2006-04-06     Completed Date:  2006-08-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0210174     Medline TA:  Int J Gynaecol Obstet     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  5-12     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway. kjell.haram@broadpark.no
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Cortex Hormones / therapeutic use
Amniotic Fluid
Aspirin / therapeutic use
Bed Rest
Female
Fetal Development / physiology*
Fetal Growth Retardation / diagnosis*,  therapy*
Gestational Age
Heparin / therapeutic use
Humans
Hyperbaric Oxygenation
Imaging, Three-Dimensional
Pregnancy
Prenatal Diagnosis*
Risk Factors
Ultrasonography, Prenatal / methods
Chemical
Reg. No./Substance:
0/Adrenal Cortex Hormones; 50-78-2/Aspirin; 9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Low ambient temperature increases food intake and dropping production, leading to incorrect estimate...
Next Document:  Characterisation and expression of an Hsp70 gene from Parastrongyloides trichosuri.